Last reviewed · How we verify
Conceptrol
At a glance
| Generic name | Conceptrol |
|---|---|
| Sponsor | Evofem Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment (NA)
- The K-Map Study, Global Prevalence of KC
- Effectiveness of SNAPPS in Family Medicine Residency Program (NA)
- Ovulation Double Check (Proov) Verification and Usability Testing
- The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women. (PHASE2)
- Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel (PHASE3)
- Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage (NA)
- A Study of the Effects of Advantage 24 on the Rectum (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Conceptrol CI brief — competitive landscape report
- Conceptrol updates RSS · CI watch RSS
- Evofem Inc. portfolio CI